Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these figures provides insight into the shifting landscape of the pharmaceutical ...

"Year to date" sales for 2021, 2022, 2023, and 2024 sales are shown in series at the top of the table and then just below a comparison of 2024 versus 2023 and 2024 versus 2022 is displayed.

Stelara, used to treat plaque psoriasis ... The drug is used to treat a form of blood cancer known as myeloma. AbbVie’s (ABBV) Skyrizi generated $11.7 billion in sales in 2024 — about 20% ...

"Year to date" sales for 2021, 2022, 2023, and 2024 sales are shown in series at the top of the table and then just below a comparison of 2024 versus 2023 and 2024 versus 2022 is displayed.

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ahead of AbbVie’s Rinvoq and Skyrizi three months into its ...

J&J has phase 2 results in hand with Tremfya in Crohn's, but Lilly's mirikizumab is closest behind Skyrizi, with results of a head-to-head trial pitting the antibody against Stelara due later this ...

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting off on a very different note. According to iSpot.TV’s analysis of ...

In Crohn's, Skyrizi, Stelara, and Ilumya are already approved by the FDA, while Tremfya is under review, having been submitted to the regulator last June. In the VIVID-1 trial, patients treated ...

reached clinical remission after 6 months on risankizumab (Skyrizi) versus ustekinumab (Stelara), according to a head-to-head trial. In the phase III study, 59% of patients (n=255) receiving ...

No significant differences were observed between Stelara and Entyvio in the 3-year ... electronic health record data from TriNetX to compare the risk for major adverse cardiovascular events ...

Lola Young’s breakthrough hit Messy transcends its TikTok virality to finally take the top spot on this week’s Official Singles Chart. Displacing Gracie Abrams’ That’s So True after a ...